Date: 6/5/2008
Length: 00:06:39
Size: 3.04MB
Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting
In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment